- FDA “Breakthrough Device Designation”
- Tox Study Completion
- WMIC 2019 Poster
- Q&A with Bob Proulx
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance